Characteristic | All patients (n = 215) | Primary site | P | |
---|---|---|---|---|
Nasal (n = 170) | Extra-nasal (n = 45) | |||
Sex | 0.594 | |||
Men | 141 (65.6) | 113 (66.5) | 28 (62.2) | |
Women | 74 (34.4) | 57 (33.5) | 17 (37.8) | |
Age (years) | 0.404 | |||
≤60 | 188 (87.4) | 147 (86.5) | 41 (91.1) | |
>60 | 27 (12.6) | 23 (13.5) | 4 (8.9) | |
Regional lymph node involvement | 0.150 | |||
Yes | 67 (31.2) | 49 (28.8) | 18 (40.0) | |
No | 148 (68.8) | 121 (71.2) | 27 (60.0) | |
“B” symptoms | 0.048 | |||
Yes | 87 (40.5) | 63 (37.1) | 24 (53.3) | |
No | 128 (59.5) | 107 (62.9) | 21 (46.7) | |
Elevated LDH | 0.675 | |||
Yes | 43 (20.0) | 35 (20.6) | 8 (17.8) | |
No | 172 (80.0) | 135 (79.4) | 37 (82.2) | |
LTI | 0.137 | |||
Yes | 126 (58.6) | 104 (61.2) | 22 (48.9) | |
No | 89 (41.4) | 66 (38.8) | 23 (51.1) | |
ECOG score | 0.773 | |||
0–1 | 207 (96.3) | 164 (96.5) | 43 (95.6) | |
≥2 | 8 (3.7) | 6 (3.5) | 2 (4.4) |